Transport of maternal cholesterol to the fetus is affected by maternal plasma cholesterol concentrations in the Golden Syrian hamster

Journal of Lipid Research

Volumn 50, Issue 6, 2009, Pages 1146-1155

  Burke, Katie T ^a   Colvin, Perry L ^b   Myatt, Leslie ^a   Graf, Gregory A ^c   Schroeder, Friedhelm ^d   Woollett, Laura A ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

^d TEXAS A AND M UNIVERSITY   (United States)

Author keywords

High density lipoprotein; Liver X receptor; Low density lipoprotein; NPC1 Like 1; Placenta; Smith Lemli Opitz Syndrome; Yolk sac

Indexed keywords

ABC TRANSPORTER A1; ABC TRANSPORTER G1; CARRIER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LIVER X RECEPTOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; NIEMANN PICK C1 PROTEIN; NIEMANN PICK C1L1 PROTEIN; STEROL CARRIER PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; FEMALE; FETUS; GENE EXPRESSION; LIPOPROTEIN SECRETION; MALE; MATERNAL PLASMA; MOTHER FETUS RELATIONSHIP; NONHUMAN; PLACENTA; PRIORITY JOURNAL; SYRIAN HAMSTER; YOLK SAC;

ANIMALS; BIOLOGICAL TRANSPORT, ACTIVE; CHOLESTEROL; CHOLESTEROL, DIETARY; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CRICETINAE; DNA-BINDING PROTEINS; FEMALE; FETUS; HUMANS; INFANT, NEWBORN; MALE; MATERNAL-FETAL EXCHANGE; MEMBRANE PROTEINS; MESOCRICETUS; PLACENTA; PREGNANCY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, MESSENGER; SMITH-LEMLI-OPITZ SYNDROME; YOLK SAC;

EID: 67650564159     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M800538-JLR200     Document Type: Article

References (84)

1. Porter, J. A., K. E. Young, and P. A. Beachy. 1996. Cholesterol modification of hedgehog signaling proteins in animal development. Science. 274: 255-259.
2. Cooper, M. K., C. A. Wassif, P. A. Krabowiak, J. Taipale, R. Gong, R. I. Kelley, F. D. Porter, and P. A. Beachy. 2003. A defective response to Hedgehog signaling in disorders of cholesterol biosynthesis. Nat. Genet. 33: 508-513.
3. Salameh, W. A., and D. S. Matrogiannis. 1994. Maternal hyperlipidemia in pregnancy. Clin. Obstet. Gynecol. 37: 66-77.
4. Potter, J. M., and P. J. Nestel. 1979. The hyperlipidemia of pregnancy in normal and complicated pregnancies. Am. J. Obstet. Gynecol. 133: 165-170.
5. Wyne, K. L., and L. A. Woollett. 1998. Transport of maternal LDL and HDL to the fetal membranes and placenta of the Golden Syrian hamster is mediated by receptor-dependent and receptor-independent processes. J. Lipid Res. 39: 518-530.
6. Shi, W., K. F. Swan, S. R. Lear, J. S. O'Neil, S. K. Erickson, and M. C. Henson. 1999. Regulation of pathways determining cholesterol availability in the baboon placenta with advancing gestation. Biol. Reprod. 61: 1499-1505.
7. Brown, M. S., and J. L. Goldstein. 1986. A receptor-mediated pathway for cholesterol homeostasis. Science. 232: 34-47.
8. Ory, D. S. 2000. Niemann-Pick type C: a disorder of cellular cholesterol trafficking. Biochim. Biophys. Acta. 1529: 331-339.
9. Wojtanik, K. M., and L. Liscum. 2003. The transport of low density lipoprotein-derived cholesterol to the plasma membrane is defective in NPC1 cells. J. Biol. Chem. 278: 14850-14856.
10. Hatzopoulos, A. K., A. Rigotti, R. D. Rosenberg, and M. Krieger. 1998. Temporal and spatial pattern of expression of the HDL receptor SR-BI during murine embryogenesis. J. Lipid Res. 39: 495-508.
11. Hammad, S. M., S. Stefansson, W. O. Twal, C. J. Drake, P. Fleming, A. Remaley, H. B. Brewer, Jr., and W. S. Argraves. 1999. Cubilin, the endocytic receptor for intrinsic factor-vitamin B12 complex, mediates high-density lipoprotein holoparticle endocytosis. Proc. Natl. Acad. Sci. USA. 96: 10158-10163.
12. Kozyraki, R., J. Fyfe, M. Kristiansen, C. Gerdes, C. Jacobsen, S. Cui, E. I. Christensen, M. Aminoff, A. de la Chapelle, R. Krahe, et al. 1999. The intrinsic factor-vitamin B12 receptor, cubilin, is a high-affinity apolipoprotein A-I receptor facilitating endocytosis of high-density lipoprotein. Nat. Med. 5: 656-661.
13. Smith, B. T., J. C. Mussell, P. A. Fleming, J. L. Barth, D. D. Spyropoulos, M. A. Cooley, C. J. Drake, and W. S. Argraves. 2006. Targeted disruption of cubilin reveals essential developmental roles in the structure and function of endoderm and in somite formation. BMC Dev. Biol. 6: 30-41.
14. Zanlungo, S., A. Rigotti, and F. Nervi. 2004. Hepatic cholesterol transport from plasma into bile: implications for gallstone disease. Curr. Opin. Lipidol. 15: 279-286.
15. Mack, J. T., D. M. Townsend, V. Beljanski, and K. D. Tew. 2007. The ABCA2 transporter: intracellular roles in trafficking and metabolism of LDL-derived cholesterol and sterol-related compounds. Curr. Drug Metab. 8: 47-57.
16. Yu, L. 2008. The structure and function of Niemann-Pick C1-like 1 protein. Curr. Opin. Lipidol. 19: 263-269.
17. Hui, D. Y., E. D. Labonte, and P. N. Howles. 2008. Development and physiological regulation of intestinal lipid absorption. III. Intestinal transporters and cholesterol absorption. Am. J. Physiol. Gastrointest. Liver Physiol. 294: G839-G843.
18. Oram, J. F., and A. M. Vaughan. 2006. ATP-Binding cassette cholesterol transporters and cardiovascular disease. Circ. Res. 99: 1031-1043.
19. Irons, M., E. R. Elias, G. Salen, G. S. Tint, and A. K. Batta. 1993. Defective cholesterol biosynthesis in Smith-Lemli-Opitz syndrome. Lancet. 341: 1414.
20. Tint, G. S., M. Irons, E. R. Elias, A. K. Batta, R. Frieden, T. S. Chen, and G. Salen. 1994. Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome. N. Engl. J. Med. 330: 107-113.
21. 7-reductase activity in chorionic villi. Prenat. Diagn. 20: 238-240.
22. Nowaczyk, M. J. M., S. A. Farrell, W. L. Sirkin, L. Velsher, P. A. Krakowiak, J. S. Waye, and F. D. Porter. 2001. Smith-Lemli-Opitz (RHS) syndrome: holoprosencephaly and homozygous IVS8-1G to C genotype. Am. J. Med. Genet. 103: 75-80.
23. Witsch-Baumgartner, M., M. Gruber, H. G. Kraft, M. Rossi, P. Clayton, M. Giros, D. Haas, R. I. Kelley, M. Krajewska-Walasek, and G. Utermann. 2004. Maternal apo E genotype is a modifier of the Smith-Lemli-Opitz syndrome. J. Med. Genet. 41: 577-584.
24. Lin, D. S., R. M. Pitkin, and W. E. Connor. 1977. Placental transfer of cholesterol into the human fetus. Am. J. Obstet. Gynecol. 128: 735-739.
25. Pitkin, R. M., W. E. Connor, and D. S. Lin. 1972. Cholesterol metabolism and placental transfer in the pregnant rhesus monkey. J. Clin. Invest. 51: 2584-2592.
26. Plotz, E. J., J. J. Kabara, M. E. Davis, G. V. LeRoy, and R. G. Gould. 1968. Studies on the synthesis of cholesterol in the brain of the human fetus. Am. J. Obstet. Gynecol. 101: 534-538.
27. Tint, G. S., H. Yu, Q. Shang, G. Xu, and S. B. Patel. 2006. The use of the Dhcr7 knockout mouse to accurately determine the origin of fetal sterols. J. Lipid Res. 47: 1535-1541.
28. Yoshida, S., and Y. Wada. 2005. Transfer of maternal cholesterol to embryo and fetus in pregnant mice. J. Lipid Res. 46: 2168-2174.
29. McConihay, J. A., P. S. Horn, and L. A. Woollett. 2001. The effect of maternal hypercholesterolemia on fetal sterol metabolism in the Golden Syrian hamster. J. Lipid Res. 42: 1111-1119.
30. Hayden Lichtenberg, M., C. S. Wilke, J. A. McConihay, N. A. Granholm, and L. A. Woollett. 2005. Yolk sac cholesteryl ester secretion rates can be manipulated in the Golden Syrian hamster: effect of yolk sac cholesterol concentrations. Biochim. Biophys. Acta. 1735: 214-221.
31. Schmid, K. E., W. S. Davidson, L. Myatt, and L. A. Woollett. 2003. The transport of cholesterol across a BeWo cell monolayer: implications for net transport of sterol from the maternal to fetal circulation. J. Lipid Res. 44: 1909-1918.
32. Irons, M., E. R. Elias, D. Abuelo, M. J. Bull, C. L. Greene, V. P. Johnson, L. Keppen, C. Schanen, G. S. Tint, and G. Salen. 1997. Treatment of Smith-Lemli-Opitz syndrome: results of a multi-center trial. Am. J. Med. Genet. 68: 311-314.
33. Elias, E. R., M. B. Irons, A. D. Hurley, G. X. Tint, and G. Salen. 1997. Clinical effects of cholesterol supplementation in six patients with the Smith-Lemli-Opitz syndrome (SLOS). Am. J. Med. Genet. 68: 305-310.
34. Tint, G. S., G. Salen, A. K. Batta, S. Shefer, M. Irons, E. R. Elias, D. N. Abuelo, V. P. Johnson, M. Lambert, and R. Lutz. 1995. Correlation of severity and outcome with plasma sterol levels in variants of the Smith-Lemli-Opitz syndrome. J. Pediatr. 127: 82-87.
35. 7-sterol reductase gene and genotype-phenotype correlation in 84 patients with Smith-Lemli-Opitz syndrome. Am. J. Hum. Genet. 66: 402-412.
36. Cunniff, C. M. 2004. Smith-Lemli-Opitz Syndrome. Gene Reviews. www.genetests.org.
37. Clausen, T., T. K. Burski, N. Oyen, K. Godang, J. Bollerslev, and T. Henriksen. 2005. Maternal anthropometric and metabolic factors in the first half of pregnancy and risk of neonatal macrosomia in term pregnancies. A prospective study. Eur. J. Endocrinol. 153: 887-894.
38. Wadsack, C., S. Tabano, A. Maier, U. Hiden, G. Alvino, V. Cozzi, M. Huttinger, W. J. Schneider, U. Lang, I. Cetin, et al. 2006. Intrauterine growth restriction (IUGR) is associated with alterations in placental lipoprotein receptors and maternal lipoprotein composition. Am. J. Physiol. Endocrinol. Metab. 292: E476-E484.
39. Edison, R. J., K. Berg, A. Remaley, R. Kelley, C. Rotimi, R. E. Stevenson, and M. Muenke. 2007. Adverse birth outcome among mothers with low serum cholesterol. Pediatrics. 120: 723-733.
40. Napoli, C., F. P. D'Armiento, F. P. Mancini, A. Postiglione, J. L. Wiztum, G. Palumbo, and W. Palinski. 1997. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of LDL and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J. Clin. Invest. 100: 2680-2690.
41. McConihay, J. A., A. M. Honkomp, N. A. Granholm, and L. A. Woollett. 2000. Maternal high density lipoproteins affect fetal mass and extra-embryonic fetal tissue sterol metabolism in the mouse. J. Lipid Res. 41: 424-432.
42. Woollett, L. A., D. K. Spady, and J. M. Dietschy. 1989. Mechanisms by which saturated triacylglycerols elevate the plasma low density lipoprotein-cholesterol concentration in hamsters. Differential effects of fatty acid chain length. J. Clin. Invest. 84: 119-128.
43. Woollett, L. A., D. Kearney, and D. K. Spady. 1997. Diet modification alters plasma HDL cholesterol concentrations but not the transport of HDL cholesteryl esters to the liver in the hamster. J. Lipid Res. 38: 2289-2302.
44. Halperin, G., O. Stein, and Y. Stein. 1986. Synthesis of ether analogs of lipoprotein lipids and their biological applications. Methods Enzymol. 129: 816-848.
45. Su, Y. R., M. F. Linton, and S. Fazio. 2002. Rapid quantification of murine ABC mRNAs by real time reverse transcriptase-polymerase chain reaction. J. Lipid Res. 43: 2180-2187.
46. Jia, X., N. Ebine, I. Demonty, Y. Wang, R. Beech, V. Muise, M. G. Fortin, and P. J. H. Jones. 2007. Hypocholesterolaemic effects of plant sterol analogues are independent of ABCG5 and ABCG8 transporter expressions in hamsters. Br. J. Nutr. 98: 550-555.
47. Jelinek, D. F., S. Andersson, C. A. Slaughter, and D. W. Russell. 1990. Cloning and regulation of cholesterol 7α-hydroxylase, the rate-limiting enzyme in bile acid biosynthesis. J. Biol. Chem. 265: 8190-8197.
48. Graf, G. A., L. Yu, W. P. Li, R. Gerard, P. L. Tuma, J. C. Cohen, and H. H. Hobbs. 2003. ABCG5 and ABCG8 are obligate heterodimers for protein trafficking and biliary cholesterol excretion. J. Biol. Chem. 278: 48275-48282.
49. Atshaves, B. P., A. Petrescu, O. Starodub, J. Roths, A. B. Kier, and F. Schroeder. 1999. Expression and intracellular processing of the 58 kDa Sterol Carrier Protein 2/3-Oxoacyl-CoA Thiolase in transfected mouse L-cell fibroblasts. J. Lipid Res. 40: 610-622.
50. Woollett, L. A. 2008. Where does fetal and embryonic cholesterol originate and what does it do? Annu. Rev. Nutr. 28: 97-114.
51. Dietschy, J. M., S. D. Turley, and D. K. Spady. 1993. Role of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including humans. J. Lipid Res. 34: 1637-1659.
52. Spady, D. K., D. W. Bilheimer, and J. M. Dietschy. 1983. Rates of receptor-dependent and -independent low density lipoprotein uptake in the hamster. Proc. Natl. Acad. Sci. USA. 80: 3499-3503.
53. Spady, D. K., and J. M. Dietschy. 1985. Dietary saturated triacylglycerols suppress hepatic low density lipoprotein receptor activity in the hamster. Proc. Natl. Acad. Sci. USA. 82: 4526-4530.
54. Yao, L., K. Jenkins, P. S. Horn, M. H. Lichtenberg, and L. A. Woollett. 2007. Inability to fully suppress sterol synthesis rates with exogenous sterol in embryonic and extraembyronic fetal tissues. Biochim. Biophys. Acta. 1171: 1372-1379.
55. Xie, C., L. A. Woollett, S. D. Turley, and J. M. Dietschy. 2002. Fatty acids differentially regulate hepatic cholesteryl ester formation and incorporation into lipoproteins in the liver of the mouse. J. Lipid Res. 43: 1508-1519.
56. Porter, F. D. 2000. RSH/Smith-Lemli-Opitz Syndrome: a multiple congenital anomaly/mental retardation syndrome due to an inborn error of cholesterol biosynthesis. Mol. Genet. Metab. 71: 163-174.
57. Lanford, R. E., D. L. Bronson, L. E. Estlack, and F. H. Wians, Jr. 1991. Plasma protein and apolipoprotein synthesis by human yolk sac carcinoma cells in vitro. In Vitro Cell. Dev. Biol. 27A: 205-210.
58. Farese, R. V., Jr., S. Cases, S. L. Ruland, H. J. Kayden, J. S. Wong, S. G. Young, and R. L. Hamilton. 1996. A novel function for apolipoprotein B: lipoprotein synthesis in the yolk sac is critical for maternal-fetal lipid transport in mice. J. Lipid Res. 37: 347-360.
59. Plonné, D., L. Winkler, H. Franke, and R. Dargel. 1992. The visceral yolk sac - an important site of synthesis and secretion of apolipoprotein B containing lipoproteins in the feto-placental unit of the rat. Biochim. Biophys. Acta. 1127: 174-185.
60. Plosch, T., E. M. E. van Straten, and S. F. Kuipers. 2007. Cholesterol transport by the placenta: placental liver X receptor activity as a modulator of fetal cholesterol metabolism? Placenta. 28: 604-610.
61. Laffitte, B. A., J. J. Repa, S. B. Joseph, D. C. Wilpitz, H. R. Kast, D. J. Mangelsdorf, and P. Tontonoz. 2001. LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes. Proc. Natl. Acad. Sci. USA. 98: 507-512.
62. Wang, N., D. Lan, W. Chen, F. Matsuruar, and A. R. Tall. 2004. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc. Natl. Acad. Sci. USA. 101: 9774-9779.
63. Lindegaard, M. L., C. A. Wassif, B. Varisman, M. Amar, E. V. Wasmuth, R. Shamburek, L. B. Nielsen, A. T. Remaley, and F. D. Porter. 2008. Characterization of placental cholesterol transport: ABCA1 is a potential target for in utero therapy of Smith-Lemli-Opitz syndrome. Hum. Mol. Genet. 17: 3806-3813.
64. Repa, J. J., K. K. Buhman, R. V. J. Farese, J. M. Dietschy, and S. D. Turley. 2004. ACAT2 deficiency limits cholesterol absorption in the cholesterol-fed mouse: impact on hepatic cholesterol homeostasis. Hepatology. 40: 1088-1097.
65. Spady, D. K., J. B. Meddings, and J. M. Dietschy. 1986. Kinetic constants for receptor-dependent and receptor-independent low density lipoprotein transport in the tissues of the rat and hamster. J. Clin. Invest. 77: 1474-1481.
66. Spady, D. K., L. A. Woollett, and J. M. Dietschy. 1993. Regulation of plasma LDL-cholesterol levels by dietary cholesterol and fatty acids. Annu. Rev. Nutr. 13: 355-381.
67. Powell, T. L., T. Jansson, N. P. Illsley, M. Wennergren, M. Korotkova, and B. Strandvik. 1999. Composition and permeability of syncytiotrophoblast plasma membranes in pregnancies complicated by intrauterine growth restriction. Biochim. Biophys. Acta. 1420: 86-94.
68. Ethier-Chiasson, M., A. Duchesne, J-C. Forest, Y. Giguère, A. Masse, C. Mounier, and J. Lafond. 2007. Influence of maternal lipid profile on placental protein expression of LDLr and SR-BI. Biochem. Biophys. Res. Commun. 359: 8-14.
69. Marseille-Tremblay, C., M. Ethier-Chiasson, J-C. Forest, Y. Giguère, A. Masse, C. Mounier, and J. Lafond. 2008. Impact of maternal circulating cholesterol and gestational diabetes mellitus on lipid metabolism in human term placenta. Mol. Reprod. Dev. 75: 1054-1062.
70. Gèvry, N., K. Schoonjams, F. Guay, and B. D. Murphy. 2008. Cholesterol supply and SREBPs modulate transcription of the Niemann-Pick C-1 gene in steroidogenic tissues. J. Lipid Res. 49: 1024-1033.
71. Ge, L., J. Wang, W. Qi, H. H. Hiao, J. Cao, Y. X. Qu, B. L. Li, and B. L. Song. 2008. The cholesterol absorption inhibitor ezetimibe acts by blocking the sterol-induced internalization of NPC1L1. Cell Metab. 7: 508-519.
72. Baum, C. L., S. Kansal, and N. O. Davidson. 1993. Regulation of sterol carrier protein-2 gene expression in rat liver and small intestine. J. Lipid Res. 34: 729-739.
73. Kaminski, W. E., A. Piehler, K. Püllmann, M. Porsch-Ozcürümez, C. Duong, G. M. Bared, C. Buchler, and G. Schmitz. 2001. Complete coding sequence, promoter region, and genomic structure of the human ABCA2 gene and evidence for sterol-dependent regulation in macrophages. Biochem. Biophys. Res. Commun. 281: 249-258.
74. Boguslawski, W., and W. Sokolowski. 1984. HMG-CoA reductase activity in the microsomal fraction from human placenta in early and term pregnancy. Int. J. Biochem. 16: 1023-1026.
75. Simpson, E. R., J. C. Porter, L. Milewich, D. W. Bilheimer, and P. C. MacDonald. 1978. Regulation by plasma lipoproteins of progesterone biosynthesis and 3-hydroxy-3-methyl glutaryl coenzyme A reductase activity in cultured human choriocarcinoma cells. J. Clin. Endocrinol. Metab. 47: 1099-1105.
76. Woollett, L. A. 1996. Origin of cholesterol in the fetal Golden Syrian hamster: contribution of de novo sterol synthesis and maternal-derived lipoprotein cholesterol. J. Lipid Res. 37: 1246-1257.
77. Belknap, W. M., and J. M. Dietschy. 1988. Sterol synthesis and low density lipoprotein clearance in vivo in the pregnant rat, placenta, and fetus. Sources for tissue cholesterol during fetal development. J. Clin. Invest. 82: 2077-2085.
78. Tulenko, T. N., K. Boeze-Battaglia, R. P. Mason, G. S. Tint, R. D. Steiner, W. E. Connor, and E. F. Labelle. 2006. A membrane defect in the pathogenesis of the Smith-Lemli-Opitz syndrome. J. Lipid Res. 47: 134-143.
79. Kovarova, M., C. A. Wassif, S. Odom, K. Liao, F. D. Porter, and J. Rivera. 2006. Cholesterol deficiency in a mouse model of Smith-Lemli-Opitz syndrome reveals increased mast cell responsiveness. J. Exp. Med. 203: 1161-1171.
80. Keller, R. K., T. P. Arnold, and S. J. Fliesler. 2004. Formation of 7-dehydrocholesterol-containing membrane rafts in vitro and in vivo, with relevance to the Smith-Lemli-Opitz syndrome. J. Lipid Res. 45: 347-355.
81. Cooper, M. K., J. A. Porter, K. E. Young, and P. A. Beachy. 1998. Teratogen-mediated inhibition of target tissue response to Shh signaling. Science. 280: 1603-1607.
82. Barker, D. J. P. 2004. The developmental origins of adult disease. J. Am. Coll. Nutr. 23: 588S-595S.
83. Boney, C. M., A. Verma, R. Tucker, and B. R. Vohr. 2005. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics. 115: e290-e296.
84. Samaras, T. T., H. Elrick, and L. H. Storms. 2003. Birthweight, rapid growth, cancer, and longevity: a review. J. Natl. Med. Assoc. 95: 1170-1183.